Literature DB >> 17055764

L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease.

M Felice Ghilardi1, Andrew S Feigin, Fortunato Battaglia, Giulia Silvestri, Paul Mattis, David Eidelberg, Alessandro Di Rocco.   

Abstract

We have recently introduced a set of sequence learning tasks that emphasize explicit learning and target anticipation and involve the activation of frontal lobes. This type of learning is impaired even in the early stages of Parkinson's disease (PD). Studies on the effects of L-Dopa on cognitive symptoms of PD have yielded controversial results. To verify whether L-Dopa acutely improves explicit sequence learning, we tested six normal subjects and seven PD patients both off-drug and during L-Dopa infusion with two tasks: SEQ, a motor task with multiple demands, where a sequence had to be learned while reaching for a targets; VSEQ, a visual task where a sequence had to be learned by attending to a visual display without moving. Motor performance was assessed with simple motor tasks. L-Dopa improved motor scores and movement speed, but had no beneficial effect on either type of sequence learning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055764     DOI: 10.1016/j.parkreldis.2006.08.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  20 in total

1.  The serial reaction time task revisited: a study on motor sequence learning with an arm-reaching task.

Authors:  Clara Moisello; Domenica Crupi; Eugene Tunik; Angelo Quartarone; Marco Bove; Giulio Tononi; M Felice Ghilardi
Journal:  Exp Brain Res       Date:  2008-12-23       Impact factor: 1.972

2.  Learning of a sequential motor skill comprises explicit and implicit components that consolidate differently.

Authors:  M Felice Ghilardi; Clara Moisello; Giulia Silvestri; Claude Ghez; John W Krakauer
Journal:  J Neurophysiol       Date:  2008-12-10       Impact factor: 2.714

Review 3.  Dopamine overdose hypothesis: evidence and clinical implications.

Authors:  David E Vaillancourt; Daniel Schonfeld; Youngbin Kwak; Nicolaas I Bohnen; Rachael Seidler
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

4.  Tracking neural correlates of successful learning over repeated sequence observations.

Authors:  Natalie A Steinemann; Clara Moisello; M Felice Ghilardi; Simon P Kelly
Journal:  Neuroimage       Date:  2016-05-05       Impact factor: 6.556

5.  Dorsal striatum mediates deliberate decision making, not late-stage, stimulus-response learning.

Authors:  Nole M Hiebert; Adrian M Owen; Ken N Seergobin; Penny A MacDonald
Journal:  Hum Brain Mapp       Date:  2017-09-25       Impact factor: 5.038

6.  Acquisition and retention of motor sequences: the effects of time of the day and sleep.

Authors:  Svetlana Kvint; Brian Bassiri; April Pruski; John Nia; Israel Nemet; Melissa Lopresti; Bernardo Perfetti; Clara Moisello; Giulio Tononi; M Felice Ghilardi
Journal:  Arch Ital Biol       Date:  2011-09       Impact factor: 1.000

Review 7.  The many facets of motor learning and their relevance for Parkinson's disease.

Authors:  Lucio Marinelli; Angelo Quartarone; Mark Hallett; Giuseppe Frazzitta; Maria Felice Ghilardi
Journal:  Clin Neurophysiol       Date:  2017-04-09       Impact factor: 3.708

8.  Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease.

Authors:  M F Ghilardi; G Silvestri; A Feigin; P Mattis; D Zgaljardic; C Moisello; D Crupi; L Marinelli; A Dirocco; D Eidelberg
Journal:  Parkinsonism Relat Disord       Date:  2008-03-03       Impact factor: 4.891

9.  Verbal implicit sequence learning in persons who stutter and persons with Parkinson's disease.

Authors:  Sarah Smits-Bandstra; Vincent Gracco
Journal:  J Mot Behav       Date:  2013-07-11       Impact factor: 1.328

10.  Performance of a motor task learned on levodopa deteriorates when subsequently practiced off.

Authors:  Elise D Anderson; Fay B Horak; Michael R Lasarev; John G Nutt
Journal:  Mov Disord       Date:  2013-10-16       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.